13F
中

TIL INSTIL BIO INC

2026Q1 · CUSIP 45783C200 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
31
Δ holders QoQ
+3
Breadth percentile
Top 50%
Whale holders
16
Δ whales
+4
Inst. holding value
$19M
New positions
10
Closed positions
7
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2024Q1: Δ+1 · h=31 2024Q2: Δ-1 · h=30 2024Q3: Δ+19 · h=49 2024Q4: Δ-9 · h=40 2025Q1: Δ+3 · h=43 2025Q2: Δ-5 · h=38 2025Q3: Δ-5 · h=33 2025Q4: Δ-5 · h=28 2026Q1: Δ+3 · h=31 2024Q1: holders=31 2024Q2: holders=30 2024Q3: holders=49 2024Q4: holders=40 2025Q1: holders=43 2025Q2: holders=38 2025Q3: holders=33 2025Q4: holders=28 2026Q1: holders=31 -19 -9.5 +0 +9.5 +19 253952 24Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q3 Top 18% -11.1% -1.0%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-7.00
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2023-03-31: EPS -8.77 2023-06-30: EPS -2.87 2023-09-30: EPS -10.37 2023-12-31: EPS -1.99 2024-03-31: EPS -3.74 2024-06-30: EPS -2.29 2024-09-30: EPS -3.54 2024-12-31: EPS -1.82 2025-03-31: EPS -4.32 2025-06-30: EPS -3.24 2025-09-30: EPS -2.01 2025-12-31: EPS -1.13 2026-03-31: EPS -0.62 -11.41 -5.70 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)